AmpliPhi Biosciences Corp Uncategorized Contracts & Agreements
31 Contracts & Agreements
- Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 21, 2024)
- Letter Agreement, dated July 10, 2023, by and between the Company and Deborah Birx (Filed With SEC on July 11, 2023)
- Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 16, 2023)
- Letter Agreement, dated December 14, 2022, by and between Armata Pharmaceuticals, Inc. and Todd R. Patrick (Filed With SEC on December 19, 2022)
- Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 17, 2022)
- Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 18, 2021)
- Letter Agreement, dated as of March 10, 2020, by and between Armata Pharmaceuticals, Inc. and the Cystic Fibrosis Foundation (Filed With SEC on May 14, 2020)
- Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 19, 2020)
- Form of Director Appointment Letter (Filed With SEC on May 10, 2019)
- Engagement letter agreement, dated December 13, 2017, as amended on December 17, 2018, by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on March 25, 2019)
- Form of C3J Lock-Up Agreement, dated January 3, 2019, by each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)
- Form of Company Lock-Up Agreement, dated January 3, 2019, by each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)
- Form of C3J Therapeutics Support Agreement, dated January 3, 2019, by and between the Company and each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)
- Form of Company Support Agreement, dated January 3, 2019, by and between C3J Therapeutics and each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)
- AMPLIPHIBIOSCIENCES CORPORATION COMMONSTOCK ISSUANCE AGREEMENT (Filed With SEC on April 8, 2016)
- ASSET PURCHASEAGREEMENT (Filed With SEC on March 30, 2016)
- DATED 4th November 2015 (“AgreementDate”) (Filed With SEC on March 30, 2016)
- US: 4870 Sadler Rd. Suite 300, Glen Allen, VA23060 AU: Unit 7 27 Dale Street, Brookvale 2100 NSW (Filed With SEC on March 30, 2016)
- TABLE OF CONTENTS (Filed With SEC on January 21, 2014)
- Schedule 1 Relevant PatentApplications (Filed With SEC on January 21, 2014)
- AMENDMENT NO. 4 TO EXCLUSIVE SUBLICENSE AGREEMENT (Filed With SEC on August 12, 2009)
- AMENDED AND RESTATED MANUFACTURING AGREEMENT (Filed With SEC on May 7, 2009)
- The Childrens Hospital of Philadelphia Joseph Stokes, Jr., Research Institute Department of Sponsored Projects 3615 Civic Center Blvd. ARC 142 Philadelphia, PA 19104-4318 Phone... (Filed With SEC on November 1, 2006)
- Description of Document (Filed With SEC on March 10, 2006)
- Current assets (Filed With SEC on July 30, 2004)
- Legal Proceedings (Filed With SEC on March 12, 2004)
- FINANCIAL INFORMATION (Filed With SEC on October 31, 2003)
- EXHIBIT10.42 TO (Filed With SEC on March 27, 2003)
- EXHIBIT10.41 TO (Filed With SEC on March 27, 2003)
- TARGETED GENETICS CORPORATION THIRD AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on March 27, 2003)
- TARGETED GENETICS CORPORATION SECOND AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on October 11, 2002)
